Table 1.
Association of PARN, CNOT6, CNOT7 and NOC mRNA levels with clinicopathological characteristics in paired SCC specimens
| Total number of patients | PARN | CNOT6 | CNOT7 | NOC | |||||
|---|---|---|---|---|---|---|---|---|---|
| Higha (%) | p | High (%) | p | High (%) | p | High (%) | p | ||
| Characteristics | |||||||||
| Age | |||||||||
| ≤65 | 9 | 8 (88.8) | * | 7 (77.8) | 5 (55.5) | 5 (55.5) | |||
| ≥65 | 16 | 7 (43.8) | 6 (37.5) | 10 (62.5) | 12 (75.0) | ||||
| Smoking status | |||||||||
| Smokers | 21 | 11 (52.4) | 12 (57.1) | 12 (57.1) | 14 (66.7) | ||||
| Ex-smokers | 4 | 3 (75.0) | 1 (25.0) | 3 (75.0) | 2 (50.0) | ||||
| Tumor Size | |||||||||
| T1-T2 | 9 | 5 (55.5) | 7 (77.8) | 4 (45.5) | 5 (55.5) | ||||
| T3-T4 | 16 | 9 (56.3) | 6 (37.5) | 10 (62.5) | 12 (75.0) | ||||
| Lymph Node Metastasis | |||||||||
| Negative (N0-N1) | 6 | 3 (50) | 4 (66.7) | 3 (50) | 4 (66.7) | ||||
| Positive (N2-N3) | 19 | 11 (57.9) | 9 (47.4) | 12 (63.1) | 13 (68.4) | ||||
| Metastasis | |||||||||
| Negative (M0) | 14 | 11 (78.6) | 11 (78.6) | 10 (71.4) | 11 (78.6) | ||||
| Positive (M1) | 11 | 3 (27.3) | 1 (9.0) | ** | 5 (45.5) | 4 (36.4) | |||
*p < 0.05; **p < 0.01
aSamples with increased expression levels